BRPI0520797A2 - forma de dosagem farmacêutica, comprimido farmacêutico, método para quebrar um comprimido farmacêutico, método de administração de uma dose parcial de uma droga contida em um comprimido farmacêutico, método para reduzir o risco ou impedir a confusão do paciente em um tratamento, comprimido farmacêutico prensado, método para quebrar um comprimido farmacêutico prensado e método para a criação de uma quantidade precisa de uma droga - Google Patents
forma de dosagem farmacêutica, comprimido farmacêutico, método para quebrar um comprimido farmacêutico, método de administração de uma dose parcial de uma droga contida em um comprimido farmacêutico, método para reduzir o risco ou impedir a confusão do paciente em um tratamento, comprimido farmacêutico prensado, método para quebrar um comprimido farmacêutico prensado e método para a criação de uma quantidade precisa de uma drogaInfo
- Publication number
- BRPI0520797A2 BRPI0520797A2 BRPI0520797-5A BRPI0520797A BRPI0520797A2 BR PI0520797 A2 BRPI0520797 A2 BR PI0520797A2 BR PI0520797 A BRPI0520797 A BR PI0520797A BR PI0520797 A2 BRPI0520797 A2 BR PI0520797A2
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical tablet
- pharmaceutical
- breaking
- drug
- tablet
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
FORMA DE DOSAGEM FARMACêUTICA, COMPRIMIDO FARMACêUTICO, MéTODO PARA QUEBRAR UM COMPRIMIDO FARMACêUTICO, MéTODO DE ADMINISTRAçãO DE UMA DOSE PARCIAL DE UMA DROGA CONTIDA EM UM COMPRIMIDO FARMACêUTICO, MéTODO PARA REDUZIR O RISCO OU IMPEDIR A CONFUSãO DO PACIENTE EM UM TRATAMENTO, COMPRIMIDO FARMACêUTICO PRENSADO, MéTODO PARA QUEBRAR UM COMPRIMIDO FARMACêUTICO PRENSADO E MéTODO PARA A CRIAçãO DE UMA QUANTIDADE PRECISA DE UMA DROGA. Trata-se de um comprimido farmacêutico adaptado para a divisão exata de uma dose de uma droga em duas, ou em doses menores, sendo que o comprimido tem dois ou mais segmentos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2005/042120 WO2007058660A1 (en) | 2005-11-18 | 2005-11-18 | Segmented pharmaceutical dosage forms |
Publications (3)
Publication Number | Publication Date |
---|---|
BRPI0520797A2 true BRPI0520797A2 (pt) | 2009-06-09 |
BRPI0520797B1 BRPI0520797B1 (pt) | 2020-06-09 |
BRPI0520797B8 BRPI0520797B8 (pt) | 2021-05-25 |
Family
ID=38048942
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0520797A BRPI0520797B8 (pt) | 2005-11-18 | 2005-11-18 | forma de dosagem farmacêutica comprimida em bicamadas |
Country Status (9)
Country | Link |
---|---|
US (2) | US8231902B2 (pt) |
EP (1) | EP1948138A4 (pt) |
JP (1) | JP5259413B2 (pt) |
CN (1) | CN101351195A (pt) |
AU (1) | AU2005338350A1 (pt) |
BR (1) | BRPI0520797B8 (pt) |
CA (1) | CA2630154C (pt) |
MX (1) | MX2008006453A (pt) |
WO (1) | WO2007058660A1 (pt) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080075772A1 (en) * | 2006-04-13 | 2008-03-27 | Lawrence Solomon | Pharmaceutical compositions having novel scoring patterns and methods of using those compositions |
EP2029116A4 (en) * | 2006-06-19 | 2012-07-04 | Accu Break Technologies Inc | SECURE PHARMACEUTICAL FORMS |
US20110280936A1 (en) * | 2010-05-17 | 2011-11-17 | Aptapharma, Inc. | Self Breaking Tablets |
AU2011269730B2 (en) * | 2010-06-24 | 2016-05-19 | Hiley, Carina MRS | Insect bait |
EP2747757A1 (en) * | 2011-08-26 | 2014-07-02 | Wockhardt Limited | Methods for treating cardiovascular disorders |
JP2015034133A (ja) * | 2013-08-07 | 2015-02-19 | 直実 植木 | 分割錠剤 |
US9839212B2 (en) | 2015-04-16 | 2017-12-12 | Bio-Lab, Inc. | Multicomponent and multilayer compacted tablets |
CN111954523A (zh) | 2018-03-29 | 2020-11-17 | 艾维制药有限责任公司 | 左旋多巴分次剂量组合物及用途 |
CN111407734A (zh) * | 2019-01-05 | 2020-07-14 | 厦门赛诺邦格生物科技股份有限公司 | 一种阳痿早泄治疗药物的固体制剂 |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3128226A (en) | 1962-08-22 | 1964-04-07 | Hoffmann La Roche | Composition for relieving pain |
US3336200A (en) * | 1963-05-28 | 1967-08-15 | Warner Lambert Pharmaceutical | Tablet structure |
US3517871A (en) * | 1968-11-15 | 1970-06-30 | James P Gaffney | Tablet cutter |
US3927194A (en) * | 1972-12-06 | 1975-12-16 | Ives Lab Inc | Tablet formulation |
US4139589A (en) * | 1975-02-26 | 1979-02-13 | Monique Beringer | Process for the manufacture of a multi-zone tablet and tablet manufactured by this process |
US4215104A (en) * | 1979-03-26 | 1980-07-29 | Mead Johnson & Company | Multi-fractionable tablet structure |
CH648754A5 (en) * | 1979-08-16 | 1985-04-15 | Ciba Geigy Ag | Pharmaceutical slow release tablet |
DK152744C (da) * | 1982-08-13 | 1988-10-31 | Benzon As Alfred | Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat |
DK62184D0 (da) * | 1984-02-10 | 1984-02-10 | Benzon As Alfred | Diffusionsovertrukket polydepotpraeparat |
US4789546A (en) * | 1987-02-19 | 1988-12-06 | Consumer Products Corp. | Multiple-layer tablet with contrasting organoleptic characteristics |
US5158728A (en) | 1991-04-12 | 1992-10-27 | Elizabeth-Hata International, Inc. | Multi-layer medicinal tablet forming machine and method for using the same |
IT1255522B (it) * | 1992-09-24 | 1995-11-09 | Ubaldo Conte | Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita' |
IT1256393B (it) * | 1992-11-17 | 1995-12-04 | Inverni Della Beffa Spa | Forme matriciali multistrato per il rilascio controllato di principi attivi |
CA2110313C (en) | 1992-12-01 | 2004-10-26 | Edward John Roche | Pharmaceutical compositions containing a guanidinothiazole compound and antacids |
IT1264517B1 (it) * | 1993-05-31 | 1996-09-24 | Ekita Investments Nv | Compressa farmaceutica atta al rilascio in tempi successivi dei principi attivi in essa veicolati |
US6183778B1 (en) | 1993-09-21 | 2001-02-06 | Jagotec Ag | Pharmaceutical tablet capable of liberating one or more drugs at different release rates |
EP0812589B1 (en) * | 1993-12-10 | 2000-08-16 | Fujisawa Pharmaceutical Co., Ltd. | Combined antipyretic analgesic drug |
GB9401894D0 (en) | 1994-02-01 | 1994-03-30 | Rhone Poulenc Rorer Ltd | New compositions of matter |
TW483763B (en) | 1994-09-02 | 2002-04-21 | Astra Ab | Pharmaceutical composition comprising of ramipril and dihydropyridine compound |
IT1282576B1 (it) | 1996-02-06 | 1998-03-31 | Jagotec Ag | Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili |
US6919373B1 (en) | 1996-11-12 | 2005-07-19 | Alza Corporation | Methods and devices for providing prolonged drug therapy |
DE19927688A1 (de) | 1999-06-17 | 2000-12-21 | Gruenenthal Gmbh | Mehrschichttablette zur Verabreichung einer fixen Kombination von Tramadol und Diclofenac |
EP1330236A2 (en) | 2000-10-12 | 2003-07-30 | Beecham Pharmaceuticals (Pte) Limited | Formulation containing amoxicillin |
CN100341491C (zh) * | 2001-12-19 | 2007-10-10 | 阿斯特拉曾尼卡有限公司 | 新的膜衣 |
CN101632642B (zh) | 2002-01-15 | 2011-06-08 | Ucb法奇姆股份有限公司 | 口感和稳定性改善的配方 |
ITMI20020514A1 (it) * | 2002-03-12 | 2003-09-12 | Jagotec Ag | Sistema terapeutico per il rilascio controllato di uno o piu' principi attivi |
CA2481091A1 (en) * | 2002-04-05 | 2003-10-23 | Penwest Pharmaceuticals Co. | Sustained release metoprolol formulations |
BRPI0410555A (pt) | 2003-06-06 | 2006-06-20 | Takeda Pharmaceutical | preparação sólida |
EP1648422A4 (en) * | 2003-07-28 | 2007-09-19 | Reddys Lab Inc Dr | TREATMENT AND PREVENTION OF CARDIOVASCULAR ACCIDENTS |
JP2009504761A (ja) * | 2005-08-19 | 2009-02-05 | アベンティス・ファーマスーティカルズ・インコーポレイテツド | 睡眠剤と置換ビスアリール及びヘテロアリール化合物の組み合わせ物及び治療でのその使用 |
-
2005
- 2005-11-18 CA CA2630154A patent/CA2630154C/en active Active
- 2005-11-18 JP JP2008541138A patent/JP5259413B2/ja active Active
- 2005-11-18 AU AU2005338350A patent/AU2005338350A1/en not_active Abandoned
- 2005-11-18 BR BRPI0520797A patent/BRPI0520797B8/pt active IP Right Grant
- 2005-11-18 CN CNA2005800524858A patent/CN101351195A/zh active Pending
- 2005-11-18 EP EP05849729A patent/EP1948138A4/en not_active Withdrawn
- 2005-11-18 MX MX2008006453A patent/MX2008006453A/es active IP Right Grant
- 2005-11-18 WO PCT/US2005/042120 patent/WO2007058660A1/en active Application Filing
- 2005-11-18 US US10/598,355 patent/US8231902B2/en active Active
-
2011
- 2011-08-15 US US13/210,031 patent/US20110300208A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2007058660A1 (en) | 2007-05-24 |
JP2009515955A (ja) | 2009-04-16 |
BRPI0520797B1 (pt) | 2020-06-09 |
BRPI0520797B8 (pt) | 2021-05-25 |
EP1948138A4 (en) | 2012-07-11 |
US20110300208A1 (en) | 2011-12-08 |
US20080233190A1 (en) | 2008-09-25 |
CA2630154A1 (en) | 2007-05-24 |
JP5259413B2 (ja) | 2013-08-07 |
MX2008006453A (es) | 2009-01-28 |
CA2630154C (en) | 2015-06-16 |
CN101351195A (zh) | 2009-01-21 |
EP1948138A1 (en) | 2008-07-30 |
US8231902B2 (en) | 2012-07-31 |
AU2005338350A1 (en) | 2007-05-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0520797A2 (pt) | forma de dosagem farmacêutica, comprimido farmacêutico, método para quebrar um comprimido farmacêutico, método de administração de uma dose parcial de uma droga contida em um comprimido farmacêutico, método para reduzir o risco ou impedir a confusão do paciente em um tratamento, comprimido farmacêutico prensado, método para quebrar um comprimido farmacêutico prensado e método para a criação de uma quantidade precisa de uma droga | |
BRPI0513200A (pt) | uso de um anticorpo anti-igf-1r na preparação de um medicamento para tratamento combinado para malignidades não-hematológicas | |
EA200802012A1 (ru) | Фармацевтические препараты в форме раствора для дозирующих ингаляторов под давлением | |
PH12016500619A1 (en) | Dry powder inhaler | |
PE20142319A1 (es) | Tratamiento de esclerosis multiple con combinacion de laquinimod y acetato de glatiramero | |
NZ600257A (en) | Device and method for delivery of two or more drug agents | |
BRPI0418029B8 (pt) | formulação farmacêutica líquida, estável, adequada para administração parentérica que compreende um anticorpo agonista de cd40 | |
GT200500003A (es) | Composicion farmaceutica apta para la compresion directa para la administracion oral de cci-779 | |
AR089862A1 (es) | USO DE LAQUINIMOD PARA EL TRATAMIENTO DE PACIENTES CON ENFERMEDAD DE CROHN EN QUIENES FRACASO UNA TERAPIA ANTI-FACTOR DE NECROSIS TUMORAL a (ANTI-TNFa) DE PRIMERA LINEA | |
MX2010009447A (es) | Uso de antagonistas de lhrh a dosis no castrantes. | |
BR112012000862A8 (pt) | composição farmacêutica oral, composição farmacêutica oral de baixa dose para administração crônica, método de tratamento ou retardo do inicio ou desenvolvimento de uma condição, método de tratamento da dor em um indivíduo que necessita deste medicamento, método de tratamento de uma condição em um indivíduo que necessita deste medicamento | |
BR112015022465A2 (pt) | método para tratamento não-tóxico para síndrome de abstinência de drogas | |
WO2012052853A3 (en) | Oral dosing device for administration of medication | |
NO20072931L (no) | Forbedret doseringsregime av temozolomid for behandling av kreft basert pa pasientens MGMT-niva | |
WO2008142572A3 (en) | Controlled release tablet formulation containing magnesium aluminometasilicate | |
TW200628182A (en) | Injection device for administering a medication liquid | |
AR104771A1 (es) | Inhalador de polvo seco | |
BR112012030641A2 (pt) | métodos e composições para terapia farmacêutica oral | |
BR112015011778A2 (pt) | métodos para administrar e avaliar drogas de expulsão de nitrogênio para o tratamento de encefalopatia hepática | |
NZ769954A (en) | Syringe devices for use in an emergency | |
BRPI0607172A2 (pt) | método para a ministração de pelo menos uma substáncia farmaceuticamente ativa a um paciente, combinação de medicamentos e uso de pelo menos uma substáncia farmaceuticamente ativa para a fabricação de uma combinação de medicamentos | |
AR046036A1 (es) | Composiciones de risedronato y metodos para su uso | |
MX2015009546A (es) | Dosificacion aumentada de efavirenz para el tratamiento de cancer. | |
AR065139A1 (es) | Medicamento para el tratamiento de la endometriosis | |
BRPI0513186A (pt) | composição medicinal para a administração oral |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application fees: application dismissed [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 3A ANUIDADE. |
|
B08H | Application fees: decision cancelled [chapter 8.8 patent gazette] |
Free format text: REFERENTE A DESPACHO 8.6 NA RPI 2162 DE 12/06/2012. |
|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B07A | Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 09/06/2020, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 18/11/2005 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |